Xu-Dong Wei
Overview
Explore the profile of Xu-Dong Wei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
87
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li G, Zhang D, Li M, Yuan F, Hou X, He D, et al.
Sci Rep
. 2024 Oct;
14(1):23678.
PMID: 39390050
Inflammation plays a crucial role in cancer development. The neutrophil-to-lymphocyte ratio (NLR), a measure of inflammation, is obtained from a complete blood count. However, little is known about the association...
2.
Zhou J, Wang S, Yuan H, Xu Y, Huang X, Gao S, et al.
Am J Hematol
. 2023 Jun;
98(9):1394-1406.
PMID: 37366294
Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic stem cell malignancy, and allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only curable treatment. The outcomes after transplant are influenced by...
3.
Liang J, Mi R, Chen L, Wei X
Asian J Surg
. 2023 May;
46(9):4001-4002.
PMID: 37137777
No abstract available.
4.
Yan Z, Luo X, Yao S, Wang H, Chu J, Zhao S, et al.
J Microbiol Immunol Infect
. 2023 Apr;
56(4):747-756.
PMID: 37080838
Background: More and more novel anticancer drugs have been approved for patients with hematological malignancies in recent years, but HBV reactivation (HBV-R) data in this population is very scarce. This...
5.
Yang E, Mi R, Chen L, Wei X
Asian J Surg
. 2023 Mar;
46(8):3292-3293.
PMID: 36958961
No abstract available.
6.
Mao Y, Gao S, Li Y, Hao A, Liu J, Li X, et al.
Ann Transl Med
. 2022 Sep;
10(16):904.
PMID: 36111056
Background: Left thoracic approach (LTA) has been a favorable selection in surgical treatment for esophageal cancer (EC) patients in China before minimally invasive esophagectomy (MIE) is popular. This study aimed...
7.
Gui Y, Wang J, Wei X
World J Clin Cases
. 2022 Jun;
10(10):3213-3221.
PMID: 35647132
Background: Although papillary thyroid microcarcinoma (PTMC) is not considered a threatening tumor, in some cases, it can be aggressive. Metastatic thrombosis of papillary thyroid carcinoma, follicular thyroid carcinoma, Hürthle cell...
8.
Jia X, Chen L, Wei X
Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2022 Feb;
30(1):43-48.
PMID: 35123602
Objective: To explore the effect of age on the time of neutropenia after initial induction therapy for newly diagnosed acute myeloid leukemia (AML) patients. Methods: Data of 18-65 years old...
9.
Han L, Zhang J, Zhou J, Zhou K, Xu B, Li L, et al.
Leukemia
. 2021 May;
35(10):3002-3006.
PMID: 34031533
No abstract available.
10.
Lin Q, Yan Y, Liu Q, Du J, Gao X, Zuo W, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2021 Apr;
29(2):515-519.
PMID: 33812423
Objective: To study the effect of PX-12 on apoptosis of multiple myeloma (MM) cell line induced by bortezomib. Methods: MM cell line H929 cells were divided into PX-12 group, bortezomib...